Nanomedicines and Radiopharmaceuticals
Drug delivery and nanomedicine is an emerging area of human health study. Researchers are looking for drug types and administration routes where the individual drug is delivered directly to the disease site. This in turn makes it possible to avoid the adverse effects often associated with the use of medicine.
Dr. Hafeli's research focuses on drug delivery and the development of innovative nanomedicines, which include magnetic nanoparticles, microspheres, antibodies, polymersomes, hyperbranched polymers, microneedles and combinations thereof.
Through the use of imaging techniques, the Hafeli lab evaluates the effectiveness of these nanomedicines in reaching their biological target and investigates effectiveness and toxicity in in vitro and in vivo models of diseases. His research has applications in the treatment of cancer, osteoporosis, pain, and diseases of the eye, as well as in the improving of vaccinations and in imaging blood and lung perfusions.